Publication:
Unintentional monotherapy in rheumatoid arthritis patients receiving tofacitinib and drug survival rate of tofacitinib

Simple item page
dc.contributor.authorİnanç, N.
dc.contributor.authorAbacar, K.
dc.contributor.authorÖztürk, M. A.
dc.contributor.authorTufan, A.
dc.contributor.authorKaradeniz, H.
dc.contributor.authorSarı, I.
dc.contributor.authorCan, G.
dc.contributor.authorErez, Y.
dc.contributor.authorPehlivan, Yavuz
dc.contributor.authorDalkılıç, Ediz
dc.contributor.authorOcak, Tuğba
dc.contributor.authorCefle, A.
dc.contributor.authorYazıcı, A.
dc.contributor.authorŞenel, A.
dc.contributor.authorAkar, S.
dc.contributor.authorEdiboğlu, E. Durak
dc.contributor.authorKoca, S. S.
dc.contributor.authorSağır, R. Pişkin
dc.contributor.authorYılmaz, S.
dc.contributor.authorGülcemal, S.
dc.contributor.authorGündüz, O. Soysal
dc.contributor.authorBaşıbüyük, C. S.
dc.contributor.authorAlkan, S.
dc.contributor.authorCesur, T. Y.
dc.contributor.authorÖnen, F.
dc.contributor.buuauthorPEHLİVAN, YAVUZ
dc.contributor.buuauthorDALKILIÇ, HÜSEYİN EDİZ
dc.contributor.buuauthorOCAK, TUĞBA
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentİç Hastalıkları Ana Bilim Dalı
dc.contributor.departmentRomatoloji Bilim Dalı
dc.contributor.researcheridFQP-0451-2022
dc.contributor.researcheridJHC-5173-2023
dc.contributor.researcheridFPQ-5941-2022
dc.date.accessioned2024-11-28T10:44:08Z
dc.date.available2024-11-28T10:44:08Z
dc.date.issued2022-06-01
dc.descriptionBu çalışma, 01-04, Haziran 2022 tarihlerinde Location Copenhagen[Danimarka]’da düzenlenen Annual European Congress of Rheumatology (EULAR) Kongresi‘nde bildiri olarak sunulmuştur.
dc.description.sponsorshipEuropean Alliance Assoc Rheumatol
dc.identifier.doi10.1136/annrheumdis-2022-eular.5102
dc.identifier.eissn1468-2060
dc.identifier.endpage1338
dc.identifier.issn0003-4967
dc.identifier.startpage1338
dc.identifier.urihttps://doi.org/10.1136/annrheumdis-2022-eular.5102
dc.identifier.urihttps://ard.bmj.com/content/81/Suppl_1/1338.1
dc.identifier.urihttps://hdl.handle.net/11452/48638
dc.identifier.volume81
dc.identifier.wos000850279005278
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherBMJ Publishing Group
dc.relation.journalAnnals of The Rheumatic Diseases
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectRheumatology
dc.titleUnintentional monotherapy in rheumatoid arthritis patients receiving tofacitinib and drug survival rate of tofacitinib
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalı/Romatoloji Bilim Dalı
relation.isAuthorOfPublication0075f2ae-ae8a-4690-bd46-128775e8efac
relation.isAuthorOfPublication1613225c-2f43-4052-9f82-210c854edcf4
relation.isAuthorOfPublication6cb92e7a-17de-4006-944d-e9339a2b4591
relation.isAuthorOfPublication.latestForDiscovery0075f2ae-ae8a-4690-bd46-128775e8efac

Files

Collections

Yeni Yayınlar